Diagnosis of Alzheimer's disease (AD) is crucial especially for the complete comprehension
of pathology and clinical therapy of the disorder, as well as in declining the severity of the …

The diagnosis of Alzheimer's disease (AD) took a major step forward in 2012, as Food and
Drug Administration approved the first positron emission tomography tracer. In parallel to …

Alzheimer's disease (AD) is the most common form of neurodegenerative dementia that is
rapidly becoming a major health problem, especially in developed countries because of …

Alzheimer's Disease (AD) remains one of the most challenging health-related issues for our
society. It is becoming increasingly prevalent, especially in developed countries, due to the …

Abstract Alzheimer's disease (AD), an irreversible degenerative disorder, is associated with
accumulation and aggregation of amyloid-β peptides, hyperphosphorylated tau proteins …

Alzheimer's disease is a neurodegenerative disease, which affects intellectually is frequently
observed in elderly generations and genetically linked individuals. The diagnosis of this …

Alzheimer's disease (AD) is the most common form of dementia. The pathogenesis of the
disease is associated with aggregated amyloid-β, hyperphosphorylated tau, a high level of …

One of the most prevalent forms of dementia is Alzheimer's disease (AD) which causes
severe memory impairment within humans. As such, research into the early diagnosis of AD …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and is the main
cause of dementia worldwide. As the pathogenesis of AD is quite complicated, there is …

The recent literature signals a growing paradigm shift toward integrating therapeutics and
diagnostics rather than developing and deploying them separately. In this gradual move …